Sputum Type 2 markers could predict remission in severe asthma treated with anti-Interleukin-5. Moermans C, Brion C, Bock G, Graff S, et al. Chest 2023 Feb 3:S0012-3692(23)00169-1. doi: 10.1016/j.chest.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Moermans C, Brion C, Bock G, Graff S, et al. Sputum Type 2 markers could predict remission in severe asthma treated with anti-Interleukin-5. Chest 2023 Feb 3:S0012-3692(23)00169-1. doi: 10.1016/j.chest.2023.
PMID: 36740095